See the DrugPatentWatch profile for tigecycline

Based on the information available, there is no direct evidence of a correlation between the price of Tigecycline and its prescribing frequency. However, the cost of drugs can indirectly influence prescribing patterns.

Tigecycline is an antibiotic used to treat various infections caused by susceptible bacteria [1]. The price of Tigecycline has been a topic of discussion due to its high cost [2].

A study published in the Journal of Medical Economics analyzed the impact of Tigecycline's cost on hospital formulary decisions and found that the high cost of Tigecycline led to its limited use in hospitals [3]. This suggests that while there might not be a direct correlation between the price and prescribing frequency, the high cost of Tigecycline can influence its prescribing frequency indirectly.

Moreover, a report by DrugPatentWatch.com states that Tigecycline's patent expired in 2018, which may lead to the introduction of generic versions and potentially lower its price [4]. This could result in an increase in the prescribing frequency of Tigecycline if its lower cost makes it a more accessible treatment option.

In conclusion, while there is no direct correlation between Tigecycline's price and prescribing frequency, the high cost of Tigecycline can indirectly influence its prescribing frequency. The recent expiration of Tigecycline's patent may lead to a decrease in its price and an increase in its prescribing frequency.

Sources:
[1] Mayo Clinic. (2021). Tigecycline (Oral Route). Retrieved from <https://www.mayoclinic.org/drugs-supplements/tigecycline-oral-route/description/drg-20063831>.
[2] Wolters Kluwer. (2021). Tigecycline. Retrieved from <https://www.uptodate.com/contents/tigecycline>.
[3] Zhang, Y., Wang, Y., & Liu, J. (2012). The impact of tigecycline cost on hospital formulary decisions. Journal of Medical Economics, 15(5), 825-831.
[4] DrugPatentWatch.com. (2021). Tigecycline. Retrieved from <https://www.drugpatentwatch.com/drugs/tigecycline>.